Superoxide dismutase catalyzes the dismutation of the superoxide radical: two molecules of O₂^- plus two protons are converted into hydrogen peroxide and ordinary oxygen (2 O₂^- + 2 H⁺ → H₂O₂ + O₂). That single reaction is the cell's first line of defense against a byproduct of life with oxygen. For laboratories and assay developers the practical questions are more specific than the textbook reaction: which of the three human isoforms (SOD1, SOD2, SOD3) matters for a given model, how to tell enzyme mass from enzyme activity, and how to build a readout that survives real sample matrices. We provide total SOD activity assay kits, isoform-specific SOD ELISAs for SOD1, SOD2, and SOD3, matched antibody pairs for in-house development, and custom immunoassay services covering both recombinant and native SOD proteins. This review connects the biochemistry of SOD to the bench and the clinic so those assay choices make sense.

Browse More Superoxide dismutase Products

Figure 1. The reaction of superoxide catalyzed by SODs. (Source: Zheng M, et al. 2023)

What superoxide dismutase does inside the cell

Superoxide is an inevitable leak from mitochondrial respiration, NADPH oxidases, xanthine oxidase, and cytochrome P450 enzymes. At low concentrations it is a legitimate signaling molecule; at high concentrations it oxidizes DNA, proteins, and lipids, and it feeds the broader reactive oxygen species (ROS) network. SOD caps the concentration of this most upstream and most reactive species. Once it has turned superoxide into hydrogen peroxide, other systems finish the job: catalase and the glutathione-peroxidase / peroxiredoxin machinery convert H₂O₂ into water. That two-step handoff matters, because H₂O₂ is itself a signaling molecule and, if not controlled, a source of the hydroxyl radical through Fenton chemistry. SOD does not eliminate oxidative stress by itself — it sets the ceiling on the most damaging upstream radical.

Mammals express three SOD isoforms separated by where they sit and which metal they use. SOD1 is a copper- and zinc-dependent enzyme (Cu/Zn-SOD) that works mostly in the cytosol and, importantly, in the mitochondrial intermembrane space. SOD2, also called MnSOD, carries manganese and lives in the mitochondrial matrix, where the bulk of cellular superoxide is born during respiration. SOD3 is the extracellular form (ecSOD, also Cu/Zn-dependent); it is secreted and tethers to the extracellular matrix and cell surfaces through a heparin-binding domain, defending the space outside the cell. These three are not redundant — their locations decide which compartment's superoxide they control, so a "total SOD" number and an isoform-specific number tell different stories. SOD2 is also the inducible one: its transcription is tuned by Nrf2, FOXO, and p53 under oxidative stress, and its activity is adjusted after translation by acetylation, where the deacetylase SIRT3 keeps MnSOD active and excessive acetylation dulls it.

What a low or high SOD level actually means

Searches for "SOD blood test" and "SOD normal range" usually come from people who saw an oxidative-stress panel or a longevity workup. Two different measurements hide under "SOD." One is enzyme activity — how fast a sample dismutates superoxide — which depends on metal-cofactor availability (copper, zinc, manganese), sample handling, and interfering antioxidants. The other is protein mass, measured by an isoform-specific immunoassay (ELISA) that counts SOD1, SOD2, or SOD3 molecules whether or not they are catalytically active. A sample can carry plenty of SOD protein but low activity if the metal centers are incomplete or the enzyme is inhibited, so the two readouts answer different questions and should not be conflated.

Low total SOD activity is repeatedly associated with states of high oxidative burden — metabolic disease, advanced age, and several neurodegenerative and cardiovascular conditions — which is why it is promoted as an oxidative-stress biomarker. But "low SOD" is a downstream signature, not a diagnosis; it reflects many upstream problems rather than one cause. On the supplement side, oral SOD is a familiar ingredient in cosmetics and wellness products, yet the enzyme is a protein that is largely broken down in the digestive tract, so oral bioavailability is poor and the evidence for a systemic antioxidant benefit from swallowing SOD is weak. That gap is what motivates work on stabilized forms and on small-molecule SOD mimetics that reproduce the catalytic center without being a fragile protein — useful research tools and therapeutic candidates, but not established consumer products. This article is provided for scientific reference and is not medical advice.

SOD1 and the long shadow of ALS

SOD1 is the isoform most people have heard of, almost entirely because mutations in it were the first genetic cause mapped for amyotrophic lateral sclerosis (ALS). Among inherited ALS cases, SOD1 mutations account for roughly 12–20%, and they explain about 1–2% of all ALS. The finding that reshaped the field is that these are not simple loss-of-function changes: mutant SOD1 (mSOD1) gains toxic properties. The protein misfolds, loses structural stability, and forms the insoluble aggregates found in motor neurons; it also mislocalizes to the mitochondrial intermembrane space, stresses the endoplasmic reticulum, and interferes with mitophagy by sequestering adaptor proteins such as optineurin. Well-characterized substitutions (A4V, G93A, D90A, and others) illustrate how a single amino-acid change tilts a frontline antioxidant toward a driver of neurodegeneration. For assay developers this makes SOD1 a high-traffic target — wild-type and mutant forms, aggregation states, and soluble oligomers are all studied separately.

SOD2, mitochondria, cancer, and aging

SOD2 (MnSOD) sits at the busiest source of superoxide — the mitochondrial matrix — so its levels track closely with how a cell handles metabolic and oxidative stress. The relationship to disease is genuinely paradoxical. Too little SOD2 lets mitochondrial superoxide damage the matrix, DNA, and the respiratory chain, which is why SOD2 has long been described as a tumor suppressor: many cancers show reduced SOD2, and restoring it can blunt growth. Yet the same enzyme is often upregulated in established tumors, because rapidly dividing cancer cells run a hot metabolism that floods them with ROS and they need high SOD2 simply to survive. In triple-negative breast cancer, for example, high SOD2 tracks with a poor prognosis and helps build an immunosuppressive microenvironment by supporting M2-like macrophage infiltration; dialing SOD2 down curbs invasion and stem-cell traits. The resolution to the paradox is context: SOD2 is protective when it keeps physiological ROS in check, and permissive when a tumor co-opts that protection to tolerate its own oxidative load.

Aging ties back in through the same enzyme. MnSOD activity is regulated after translation by acetylation — SIRT3 removes acetyl groups to keep it active, and loss of that control dulls mitochondrial antioxidant defense. In models of metabolic stress, altered MnSOD acetylation accompanies cellular senescence and oxidative damage, and sex hormones can shift the balance, which helps explain why the same dietary or metabolic insult produces different oxidative outcomes in males and females. These are the mechanisms behind the loose association people read about between "SOD and aging."

SOD3 and the extracellular environment

SOD3 (ecSOD) is the outlier that works outside the cell, anchored to the extracellular matrix and endothelium through its heparin-binding domain. That position lets it defend the vessel wall and lung interstitium — compartments where superoxide generated by endothelial NADPH oxidases and infiltrating immune cells would otherwise erode matrix and signaling molecules. In the pulmonary circulation, SOD3 preserves the integrity of the extracellular matrix (notably hyaluronan) during hypoxia and protects against the vascular remodeling that drives pulmonary hypertension; its loss accelerates that remodeling. In metabolic disease, SOD3 carried in circulating exosomes supports blood-vessel growth and wound repair, and exercise raises exosomal SOD3 in both mice and humans — one molecular thread linking physical activity to vascular health. Because SOD3 is a copper enzyme, its function is tied to copper transport (the ATP7A transporter), which is why copper handling and SOD3 levels move together in vascular tissue.

How SOD is measured in the lab

Turning SOD into a number comes down to two philosophies. Activity assays watch the enzyme do its job: a superoxide-generating system (commonly xanthine oxidase) produces O₂^-, a reporter — cytochrome c, a tetrazolium dye such as WST-1 or NBT, or a chemiluminescent probe — reports how much superoxide escaped, and the drop caused by the sample gives activity in units. These are sensitive and economical, but they read total SOD and are sensitive to metal ions, buffers, and other antioxidants in the sample. Immunoassays read mass: an isoform-specific ELISA using SOD1, SOD2, or SOD3 antibodies counts the protein directly, independent of activity, which is what you want when the question is "how much SOD2 is this tumor expressing" rather than "is the cofactor present." Activity and mass are complementary, not interchangeable.

Sample type drives the protocol. Serum and plasma are standard for systemic readouts; tissue homogenates and cell lysates are used for compartment-specific questions; and because SOD3 is extracellular, it is the isoform most naturally measured in circulation. We supply total SOD activity kits for serum, plasma, tissue, and cell lysates, isoform-specific SOD ELISAs (SOD1 / SOD2 / SOD3) with matched antibody pairs, and custom development for recombinant or native SOD proteins, and for panels that pair SOD with catalase or glutathione peroxidase to capture the full antioxidant handoff.

Measurement notes for the bench. Match the assay to the question: use an activity assay for functional antioxidant capacity and an isoform-specific ELISA for protein abundance. Watch the metal cofactors — SOD activity depends on copper and zinc (SOD1, SOD3) and on manganese (SOD2), so chelators or incomplete lysis can artificially lower activity. Activity assays are prone to interference from other antioxidants and from high protein or pigment in the sample; validate matrix effects, especially for tissue and plant extracts. For circulation work, SOD3 is the extracellular isoform and is the one most naturally present in serum and plasma, whereas SOD1 and SOD2 are largely intracellular, so their presence in blood often reflects release or leakage. Store samples cold and process promptly; repeated freeze–thaw and hemolysis can change both activity and apparent mass.